01 1Olon S.p.A.
02 1Olon SpA
01 1Fenretinide
02 1Fenretinide Micronized
01 2Italy
NDC Package Code : 17337-0063
Start Marketing Date : 2015-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0102
Start Marketing Date : 2021-12-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Fenretinide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fenretinide, including repackagers and relabelers. The FDA regulates Fenretinide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fenretinide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fenretinide supplier is an individual or a company that provides Fenretinide active pharmaceutical ingredient (API) or Fenretinide finished formulations upon request. The Fenretinide suppliers may include Fenretinide API manufacturers, exporters, distributors and traders.
click here to find a list of Fenretinide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fenretinide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fenretinide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fenretinide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fenretinide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fenretinide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fenretinide suppliers with NDC on PharmaCompass.
We have 1 companies offering Fenretinide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
